Analysis of the optimal operation frequency with lowest time-delay jitter for an electrically triggered field-distortion spark gap

This work was stimulated by the assumption that for a gas-filled spark gap closing switch operating at a high repetition frequency, there is an optimal frequency range in which the time-delay jitter reaches a minimum value. The experiments to test this assumption use an electrically triggered, field-distortion spark gap filled with the SF6/N2 gas mixture. The results show that indeed, the time-delay jitter decreases for a range of frequencies for which the filling gas can substantially restore the interelectrode insulation before increasing at a higher operation frequency. The experimental results demonstrate the correctness of the abovepresented assumption: the time-delay jitter of the field-distortion spark gap has its minimum when the unit operates in the repetition frequency range between 20 and 30 Hz. Since the recovery time depends on the gas species and the gap distance, the optimum operation frequency range should also vary depending on the spark-gap distance and the filling gas properties

Measuring direct non-medical burden among patients with advanced non-small cell lung cancer in China: is there a difference in health status?

ObjectiveThis study was conducted to estimate the direct non-medical cost of advanced non-small cell lung cancer (NSCLC) patients and explore whether its associated factors vary by health status.MethodsData were obtained from 13 centers in five provinces for patients with advanced NSCLC in China. The direct non-medical cost of patients since the patients were diagnosed with NSCLC included the cost of transportation, accommodation, meal, hired caregiving, and nutrition. We measured patients' health status by EQ-5D-5L instrument and divided them into good (≥0.75) and poor (<0.75) groups based on the utility score. A generalized linear model (GLM) was used to assess independent associations between statistically significant factors and non-medical financial burden in health status subgroups.ResultsData from 607 patients were analyzed. The direct non-medical cost associated with advanced NSCLC since diagnosis was $2,951 per case ($4,060 in the poor health group and $2,505 in the other), with nutrition costing the most. GLM results showed that residence(Urban area vs. Rural area: −1.038, [−2.056, −0.02]), caregivers' occupation type (Farmer vs. Employee: −1.303, [−2.514, −0.093]), hospitalization frequency (0.077, [0.033, 0.12]), average length of hospital stay (0.101, [0.032, 0.17]), and pathological type (Squamous carcinoma vs. Non-squamous carcinoma: −0.852, [−1.607, −0.097]) were independent factors influencing direct non-medical cost in the poor health group. Among participants with good health status, residence (Urban area vs. Rural area: −0.621, [−1.005, −0.236]), marital status (Others vs. Married: 0.762, [0.035, 1.488]), patients' employment status, current caregiving time per day (more than 9 hours per day vs. less than 3 hours per day: 0.471, [0.134, 0.807]), duration of disease (0.015, [0.007, 0.024]), and hospitalization frequency (0.091, [0.068, 0.113]) were statistically associated factors.ConclusionThe direct non-medical economic burden of advanced NSCLC patients in China is considerable and differs by health status. Strengthening accessibility for more effective therapies and early nutritional intervention to improve prognosis, and further promoting accessible care forms within relevant healthcare insurance coverage may be potentially feasible approaches to alleviate the direct non-medical economic burden for patients and their families

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed

Targeting the TNF-α–TNFR interaction with EGCG to block NF-κB signaling in human synovial fibroblasts

The tumor necrosis factor alpha (TNF-α)–TNF-α receptor (TNFR) interaction plays a central role in the pathogenesis of various autoimmune diseases, particularly rheumatoid arthritis, and is therefore considered a key target for drug discovery. However, natural compounds that can specifically block the TNF-α–TNFR interaction are rarely reported. (-)-Epigallocatechin-3-gallate (EGCG) is the most active, abundant, and thoroughly investigated polyphenolic compound in green tea. However, the molecular mechanism by which EGCG ameliorates autoimmune arthritis remains to be elucidated. In the present study, we found that EGCG can directly bind to TNF-α, TNFR1, and TNFR2 with similar μM affinity and disrupt the interactions between TNF-α and TNFR1 and TNFR2, which inhibits TNF-α-induced L929 cell death, blocks TNF-α-induced NF-κB activation in 293-TNF-α response cell line, and eventually leads to inhibition of TNF-α-induced NF-κB signaling pathway in HFLS and MH7A cells. Thus, regular consumption of EGCG in green tea may represent a potential therapeutic agent for the treatment of TNF-α-associated diseases

Suggestions for Revegetation over the Next 30 Years Based on Precipitation in the Three North Region of China

Afforestation in the Three North Region (TNR) of China has received wide concern due to the low survival rate and threats to water security associated with the lack of available precipitation for vegetation. It is crucial to provide a spatial layout for revegetation according to the available precipitation to achieve the vegetation cover target. This study investigated the spatial pattern of precipitation, determined the suitable vegetation distribution based on the ecological water requirements and precipitation, and proposed an optimized revegetation scheme by comparing the actual and suitable vegetation patterns. The results indicated that the actual vegetation that matched the pixel-level precipitation accounted for 67.24% of the total vegetation area in the TNR. However, 18.50% of the actual forest, 21.82% of the actual shrublands, and 19.95% of the actual grasslands were overloaded with respect to precipitation. The total suitable vegetation area was reduced slightly compared to the actual vegetation area. There is still some potential for the revegetation of forest and shrublands, mainly those in the eastern and south-eastern parts of the TNR. The optimized revegetation area in the TNR was 3.04 × 106 km2, including a maintenance management type of 2.19 × 106 km2, an upgrade type of 0.49 × 106 km2, and a degradation type of 0.37 × 106 km2. Maintenance management (natural restoration) and transformation to vegetation types with lower ecological water requirements were recognized as important revegetation practices in the TNR. This study provides guidelines to adjust the Three North Shelterbelt Project policies based on precipitation data to reduce the negative impact of revegetation on the hydrological cycle